MARKET

SNBIF

SNBIF

Sanbio Co Ltd
OTCPK
5.85
NaN%
Opening 09:30 10/30 EDT
OPEN
--
PREV CLOSE
5.85
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
9.40
52 WEEK LOW
5.85
MARKET CAP
456.64M
P/E (TTM)
-19.5065
1D
5D
1M
3M
1Y
5Y
1D
SanBio Secures Larger Credit Line to Support AKUUGO Rollout in Japan
TipRanks · 10h ago
UBS Remains a Hold on SanBio Co (SNBIF)
TipRanks · 2d ago
Analysts Offer Insights on Healthcare Companies: SanBio Co (OtherSNBIF), Oruka Therapeutics (ORKA) and Entrada Therapeutics Inc (TRDA)
TipRanks · 10/19 10:50
Nomura Reaffirms Their Hold Rating on SanBio Co (SNBIF)
TipRanks · 10/07 10:36
SanBio outlines Q2 results and global regenerative medicine ambitions
TipRanks · 09/17 06:55
Analysts Have Conflicting Sentiments on These Healthcare Companies: SanBio Co (OtherSNBIF), Immutep Ltd (OtherPRRUF) and Inventiva (IVA)
TipRanks · 09/15 12:20
SanBio Narrows Interim Loss on Cost Timing and FX Gains, Keeps Full-Year Outlook
TipRanks · 09/15 06:54
SanBio Posts Continued Losses but Maintains Strong Equity Base as It Invests in Regenerative Medicine
TipRanks · 09/15 06:53
More
About SNBIF
SanBio Co Ltd is engaged in the regenerative cell business using allogeneic stem cells. The Company has the research and development base in the United States and conducts research, development, manufacture and sale of regenerative cell medicines in Japan. The Company aims to sell therapeutic agents for diseases with high unmet medical needs, mainly in diseases of the central nervous system. It is involved in the manufacture, development, non-clinical studies, clinical trials of technologies introduced from research institutes such as universities. The Company has five regenerative cell drugs, including the main product candidate SB623 (nerve regenerative cells), SB618 (function-enhancing type & Mesenchymal stem cells), SB308 (muscle stem cells), MSC1 (mesenchymal stem cells), and MSC2 (mesenchymal stem cells).

Webull offers SanBio Co Ltd stock information, including OTCPK: SNBIF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SNBIF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SNBIF stock methods without spending real money on the virtual paper trading platform.